TOP
|
特許
|
意匠
|
商標
商標ウォッチ
Twitter
他の商標を見る
公開日
2025-10-22
公報種別
公開国際商標公報
国際登録番号
1871041
国際登録日
2025-03-10
区分
第5類(薬剤)
,
第42類(科学・技術)
商品役務
Pharmaceutical preparations and substances for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders
,
autoimmune deficiency; pharmaceutical preparations for the treatment of genetic disorders; pharmaceutical preparations for the treatment of metabolic diseases; pharmaceutical preparations for the treatment of neurodegenerative diseases; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of eye diseases; pharmaceutical preparations for the treatment of cardiovascular diseases; diagnostic biomarker reagents for medical purposes; protein arrays
,
namely
,
chemically prepared protein based diagnostic reagents for detecting disease biomarkers in biological samples for medical diagnosis purposes; diagnostic kits consisting primarily of monoclonal antibodies
,
buffers
,
and reagents for use in disease testing; diagnostic preparations for medical purposes; pharmaceutical preparations for the treatment of oncological diseases and disorders
,
autoimmune diseases and disorders
,
autoimmune deficiency
,
genetic disorders
,
metabolic diseases
,
neurodegenerative diseases
,
kidney diseases
,
eye diseases
,
cardiovascular diseases; all of the foregoing excluding treatments and diagnostics for neuromuscular disorders and orphan diseases.
,
Research and development services in the field of biologics
,
namely
,
antibodies and peptides for the treatment of cancer and immunotherapies; research and development in the pharmaceutical and biotechnology fields for the treatment of cancer and immunotherapies; providing medical and scientific research information in the field of pharmaceuticals and clinical trials in the field of cancer and immunotherapies; consulting services in the fields of biotechnology
,
pharmaceutical research and development
全 65 件を表示
,
and pharmacogenetics in the field of cancer and immunotherapies; conducting research for others in the field of biotechnology
,
pharmaceutical research and development
,
laboratory testing
,
diagnostics
,
and pharmacogenetics in the field of cancer and immunotherapies; pharmaceutical research and development; research and development in the field of biologics
,
namely
,
antibodies and peptides for the field of cancer
,
immunotherapies
,
autoimmune diseases
,
autoimmune disorders
,
genetic disorders
,
metabolic diseases
,
neurodegenerative diseases
,
kidney diseases
,
eye diseases
,
and cardiovascular diseases; research and development in the field of pharmaceuticals
,
biopharmaceuticals
,
and biotechnologies for the treatment of cancer
,
immunotherapies
,
autoimmune diseases
,
autoimmune disorders
,
genetic disorders
,
metabolic diseases
,
neurodegenerative diseases
,
kidney diseases
,
eye diseases
,
and cardiovascular diseases; research and development in the field of biotechnology
,
pharmaceutical research and development
,
laboratory testing
,
diagnostics
,
and pharmacogenetics in the field of cancer
,
immunotherapies
,
autoimmune diseases
,
autoimmune disorders
,
genetic disorders
,
metabolic diseases
,
neurodegenerative diseases
,
kidney diseases eye diseases
,
and cardiovascular diseases; providing medical and scientific research information; consulting services in the field of pharmaceutical research and development; consulting services in the field of biotechnology; consulting services in the field of pharmacogenetics; research and development in the field of oncological diseases and disorders
,
autoimmune diseases and disorders
,
autoimmune deficiency
,
genetic disorders
,
metabolic diseases
,
neurodegenerative diseases
,
kidney diseases
,
eye diseases
,
cardiovascular diseases; all of the foregoing excluding treatments and diagnostics for neuromuscular disorders and orphan diseases.
基礎出願番号
99074328,88622678
基礎出願日
2025-03-08,2019-09-19
基礎出願国
US,US
出願人
DynamiCure Biotechnology, LLC
OCRテキスト
プ粗を DYNAMICURE
OCRテキスト2
OCRについて
この商標をJ-PlatPat(特許庁公式サイト)で参照する
関連商標
Bayer Consumer Care AG
SうEPAIMTHEI
8か月前
LIGAMED medical Produkte GmbH
Ligasano
1か月前
JADRAN - GALENSKI LABORATORIJ d.d.
MERALYS
10か月前
ROXALL Medizin GmbH
HYMNOX
6か月前
ROXALL Medizin GmbH
ROXALL
6か月前
ROXALL Medizin GmbH
SULGEN
6か月前
BOLERO & Co Ltd.
BOLERO
12か月前
個人
SPEEDEX
10か月前
Orkla Wound Care AB
SALVEUUICK
18日前
Orion Corporation
ORION PHARMA
9か月前
Boehringer Ingelheim Vetmedica GmbH
SOLECTUS
10か月前
MacroArray Diagnostics GmbH
3か月前
Martin Tolar
TOLION
2か月前
GlaxoSmithKline Biologicals S.A.
BRELLAFLU
3か月前
GlaxoSmithKline Biologicals S.A.
AXFLUNA
3か月前
GlaxoSmithKline Biologicals S.A.
REXFLUVA
3か月前
EXELTIS HEALTHCARE, S.L.
-YBELLE
1か月前
Huang, Ke
Huang Lab Smarter Therapeutic Delivery
6か月前
Hermes Arzneimittel GmbH
6か月前
個人
11か月前
INTACT
INTIACT REGENERATIVE
11か月前
PRIOVANT THERAPEUTICS, INC.
BEVALTIA
2か月前
Vitaco Health IP Pty Limited
MUSASHI
1か月前
Evinature Ltd
CURQD
6か月前
PECTEN GROUP S.R.L.
パ FERMENTED AVOCADO PREPARATION
9か月前
TerraPower, LLC
| TERRAPOWER ISOTOPES
10か月前
PECTEN GROUP S.R.L.
DEAVOCADO
9か月前
PAUL HARTMANN AG
JREVENTIA
6か月前
Novo Nordisk A/S
Glemway
4か月前
Novo Nordisk A/S
Anuetake
4か月前
SEBIA
っEBIA
2か月前
VISIONMED LTD
StarFill
10か月前
Annex Foods Brands Pty Ltd
11か月前
Annex Foods Brands Pty Ltd
RED ITRACTOR
11か月前
Ursapharm Arzneimittel GmbH
4か月前
Ursapharm Arzneimittel GmbH
HYLO
4か月前
続きを見る
他の商標を見る